Global Gene Engineered Subunit Vaccine Market Research Report 2023

Global Gene Engineered Subunit Vaccine Market Research Report 2023

Table of Contents
1 Gene Engineered Subunit Vaccine Market Overview
1.1 Product Overview and Scope of Gene Engineered Subunit Vaccine
1.2 Gene Engineered Subunit Vaccine Segment by Type
1.2.1 Global Gene Engineered Subunit Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Therapeutic Gene Engineered Subunit Vaccine
1.2.3 Preventative Gene Engineered Subunit Vaccine
1.3 Gene Engineered Subunit Vaccine Segment by Application
1.3.1 Global Gene Engineered Subunit Vaccine Market Value by Application: (2023-2029)
1.3.2 Human Use
1.3.3 Veterinary Use
1.4 Global Gene Engineered Subunit Vaccine Market Size Estimates and Forecasts
1.4.1 Global Gene Engineered Subunit Vaccine Revenue 2018-2029
1.4.2 Global Gene Engineered Subunit Vaccine Sales 2018-2029
1.4.3 Global Gene Engineered Subunit Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gene Engineered Subunit Vaccine Market Competition by Manufacturers
2.1 Global Gene Engineered Subunit Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gene Engineered Subunit Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gene Engineered Subunit Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Gene Engineered Subunit Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gene Engineered Subunit Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gene Engineered Subunit Vaccine, Product Type & Application
2.7 Gene Engineered Subunit Vaccine Market Competitive Situation and Trends
2.7.1 Gene Engineered Subunit Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gene Engineered Subunit Vaccine Players Market Share by Revenue
2.7.3 Global Gene Engineered Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gene Engineered Subunit Vaccine Retrospective Market Scenario by Region
3.1 Global Gene Engineered Subunit Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gene Engineered Subunit Vaccine Global Gene Engineered Subunit Vaccine Sales by Region: 2018-2029
3.2.1 Global Gene Engineered Subunit Vaccine Sales by Region: 2018-2023
3.2.2 Global Gene Engineered Subunit Vaccine Sales by Region: 2024-2029
3.3 Global Gene Engineered Subunit Vaccine Global Gene Engineered Subunit Vaccine Revenue by Region: 2018-2029
3.3.1 Global Gene Engineered Subunit Vaccine Revenue by Region: 2018-2023
3.3.2 Global Gene Engineered Subunit Vaccine Revenue by Region: 2024-2029
3.4 North America Gene Engineered Subunit Vaccine Market Facts & Figures by Country
3.4.1 North America Gene Engineered Subunit Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gene Engineered Subunit Vaccine Sales by Country (2018-2029)
3.4.3 North America Gene Engineered Subunit Vaccine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gene Engineered Subunit Vaccine Market Facts & Figures by Country
3.5.1 Europe Gene Engineered Subunit Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gene Engineered Subunit Vaccine Sales by Country (2018-2029)
3.5.3 Europe Gene Engineered Subunit Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gene Engineered Subunit Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Gene Engineered Subunit Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gene Engineered Subunit Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Gene Engineered Subunit Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gene Engineered Subunit Vaccine Market Facts & Figures by Country
3.7.1 Latin America Gene Engineered Subunit Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gene Engineered Subunit Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Gene Engineered Subunit Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gene Engineered Subunit Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Gene Engineered Subunit Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gene Engineered Subunit Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gene Engineered Subunit Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gene Engineered Subunit Vaccine Sales by Type (2018-2029)
4.1.1 Global Gene Engineered Subunit Vaccine Sales by Type (2018-2023)
4.1.2 Global Gene Engineered Subunit Vaccine Sales by Type (2024-2029)
4.1.3 Global Gene Engineered Subunit Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Gene Engineered Subunit Vaccine Revenue by Type (2018-2029)
4.2.1 Global Gene Engineered Subunit Vaccine Revenue by Type (2018-2023)
4.2.2 Global Gene Engineered Subunit Vaccine Revenue by Type (2024-2029)
4.2.3 Global Gene Engineered Subunit Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Gene Engineered Subunit Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gene Engineered Subunit Vaccine Sales by Application (2018-2029)
5.1.1 Global Gene Engineered Subunit Vaccine Sales by Application (2018-2023)
5.1.2 Global Gene Engineered Subunit Vaccine Sales by Application (2024-2029)
5.1.3 Global Gene Engineered Subunit Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Gene Engineered Subunit Vaccine Revenue by Application (2018-2029)
5.2.1 Global Gene Engineered Subunit Vaccine Revenue by Application (2018-2023)
5.2.2 Global Gene Engineered Subunit Vaccine Revenue by Application (2024-2029)
5.2.3 Global Gene Engineered Subunit Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Gene Engineered Subunit Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Gene Engineered Subunit Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Gene Engineered Subunit Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Tiantan
6.3.1 Tiantan Corporation Information
6.3.2 Tiantan Description and Business Overview
6.3.3 Tiantan Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Tiantan Gene Engineered Subunit Vaccine Product Portfolio
6.3.5 Tiantan Recent Developments/Updates
6.4 Pulike
6.4.1 Pulike Corporation Information
6.4.2 Pulike Description and Business Overview
6.4.3 Pulike Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pulike Gene Engineered Subunit Vaccine Product Portfolio
6.4.5 Pulike Recent Developments/Updates
6.5 Greffex
6.5.1 Greffex Corporation Information
6.5.2 Greffex Description and Business Overview
6.5.3 Greffex Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Greffex Gene Engineered Subunit Vaccine Product Portfolio
6.5.5 Greffex Recent Developments/Updates
6.6 CureVac
6.6.1 CureVac Corporation Information
6.6.2 CureVac Description and Business Overview
6.6.3 CureVac Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 CureVac Gene Engineered Subunit Vaccine Product Portfolio
6.6.5 CureVac Recent Developments/Updates
6.7 Yebio
6.6.1 Yebio Corporation Information
6.6.2 Yebio Description and Business Overview
6.6.3 Yebio Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Yebio Gene Engineered Subunit Vaccine Product Portfolio
6.7.5 Yebio Recent Developments/Updates
6.8 Sanofi Pasteur SA
6.8.1 Sanofi Pasteur SA Corporation Information
6.8.2 Sanofi Pasteur SA Description and Business Overview
6.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Portfolio
6.8.5 Sanofi Pasteur SA Recent Developments/Updates
6.9 Virbac
6.9.1 Virbac Corporation Information
6.9.2 Virbac Description and Business Overview
6.9.3 Virbac Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Virbac Gene Engineered Subunit Vaccine Product Portfolio
6.9.5 Virbac Recent Developments/Updates
6.10 Pfizer Inc.
6.10.1 Pfizer Inc. Corporation Information
6.10.2 Pfizer Inc. Description and Business Overview
6.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Pfizer Inc. Gene Engineered Subunit Vaccine Product Portfolio
6.10.5 Pfizer Inc. Recent Developments/Updates
6.11 Walvax Biotechnology
6.11.1 Walvax Biotechnology Corporation Information
6.11.2 Walvax Biotechnology Gene Engineered Subunit Vaccine Description and Business Overview
6.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Walvax Biotechnology Gene Engineered Subunit Vaccine Product Portfolio
6.11.5 Walvax Biotechnology Recent Developments/Updates
6.12 Kontec
6.12.1 Kontec Corporation Information
6.12.2 Kontec Gene Engineered Subunit Vaccine Description and Business Overview
6.12.3 Kontec Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Kontec Gene Engineered Subunit Vaccine Product Portfolio
6.12.5 Kontec Recent Developments/Updates
6.13 Novavax
6.13.1 Novavax Corporation Information
6.13.2 Novavax Gene Engineered Subunit Vaccine Description and Business Overview
6.13.3 Novavax Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Novavax Gene Engineered Subunit Vaccine Product Portfolio
6.13.5 Novavax Recent Developments/Updates
6.14 Sanofi Pasteur
6.14.1 Sanofi Pasteur Corporation Information
6.14.2 Sanofi Pasteur Gene Engineered Subunit Vaccine Description and Business Overview
6.14.3 Sanofi Pasteur Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sanofi Pasteur Gene Engineered Subunit Vaccine Product Portfolio
6.14.5 Sanofi Pasteur Recent Developments/Updates
6.15 Bharat Biotech
6.15.1 Bharat Biotech Corporation Information
6.15.2 Bharat Biotech Gene Engineered Subunit Vaccine Description and Business Overview
6.15.3 Bharat Biotech Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Bharat Biotech Gene Engineered Subunit Vaccine Product Portfolio
6.15.5 Bharat Biotech Recent Developments/Updates
6.16 GlaxoSmithKline
6.16.1 GlaxoSmithKline Corporation Information
6.16.2 GlaxoSmithKline Gene Engineered Subunit Vaccine Description and Business Overview
6.16.3 GlaxoSmithKline Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.16.4 GlaxoSmithKline Gene Engineered Subunit Vaccine Product Portfolio
6.16.5 GlaxoSmithKline Recent Developments/Updates
6.17 Pfizer
6.17.1 Pfizer Corporation Information
6.17.2 Pfizer Gene Engineered Subunit Vaccine Description and Business Overview
6.17.3 Pfizer Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Pfizer Gene Engineered Subunit Vaccine Product Portfolio
6.17.5 Pfizer Recent Developments/Updates
6.18 Moderna
6.18.1 Moderna Corporation Information
6.18.2 Moderna Gene Engineered Subunit Vaccine Description and Business Overview
6.18.3 Moderna Gene Engineered Subunit Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Moderna Gene Engineered Subunit Vaccine Product Portfolio
6.18.5 Moderna Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gene Engineered Subunit Vaccine Industry Chain Analysis
7.2 Gene Engineered Subunit Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gene Engineered Subunit Vaccine Production Mode & Process
7.4 Gene Engineered Subunit Vaccine Sales and Marketing
7.4.1 Gene Engineered Subunit Vaccine Sales Channels
7.4.2 Gene Engineered Subunit Vaccine Distributors
7.5 Gene Engineered Subunit Vaccine Customers
8 Gene Engineered Subunit Vaccine Market Dynamics
8.1 Gene Engineered Subunit Vaccine Industry Trends
8.2 Gene Engineered Subunit Vaccine Market Drivers
8.3 Gene Engineered Subunit Vaccine Market Challenges
8.4 Gene Engineered Subunit Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Gene Engineered Subunit Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Gene Engineered Subunit Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Gene Engineered Subunit Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gene Engineered Subunit Vaccine Sales (K Dose) of Key Manufacturers (2018-2023)
Table 5. Global Gene Engineered Subunit Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Gene Engineered Subunit Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Gene Engineered Subunit Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Gene Engineered Subunit Vaccine Average Price (US$/Dose) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Gene Engineered Subunit Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Gene Engineered Subunit Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gene Engineered Subunit Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Gene Engineered Subunit Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gene Engineered Subunit Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Engineered Subunit Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gene Engineered Subunit Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gene Engineered Subunit Vaccine Sales by Region (2018-2023) & (K Dose)
Table 18. Global Gene Engineered Subunit Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Gene Engineered Subunit Vaccine Sales by Region (2024-2029) & (K Dose)
Table 20. Global Gene Engineered Subunit Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Gene Engineered Subunit Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Gene Engineered Subunit Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Gene Engineered Subunit Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gene Engineered Subunit Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Gene Engineered Subunit Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gene Engineered Subunit Vaccine Sales by Country (2018-2023) & (K Dose)
Table 27. North America Gene Engineered Subunit Vaccine Sales by Country (2024-2029) & (K Dose)
Table 28. North America Gene Engineered Subunit Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Gene Engineered Subunit Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gene Engineered Subunit Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gene Engineered Subunit Vaccine Sales by Country (2018-2023) & (K Dose)
Table 32. Europe Gene Engineered Subunit Vaccine Sales by Country (2024-2029) & (K Dose)
Table 33. Europe Gene Engineered Subunit Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Gene Engineered Subunit Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gene Engineered Subunit Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gene Engineered Subunit Vaccine Sales by Region (2018-2023) & (K Dose)
Table 37. Asia Pacific Gene Engineered Subunit Vaccine Sales by Region (2024-2029) & (K Dose)
Table 38. Asia Pacific Gene Engineered Subunit Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Gene Engineered Subunit Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gene Engineered Subunit Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gene Engineered Subunit Vaccine Sales by Country (2018-2023) & (K Dose)
Table 42. Latin America Gene Engineered Subunit Vaccine Sales by Country (2024-2029) & (K Dose)
Table 43. Latin America Gene Engineered Subunit Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Gene Engineered Subunit Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gene Engineered Subunit Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gene Engineered Subunit Vaccine Sales by Country (2018-2023) & (K Dose)
Table 47. Middle East & Africa Gene Engineered Subunit Vaccine Sales by Country (2024-2029) & (K Dose)
Table 48. Middle East & Africa Gene Engineered Subunit Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Gene Engineered Subunit Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gene Engineered Subunit Vaccine Sales (K Dose) by Type (2018-2023)
Table 51. Global Gene Engineered Subunit Vaccine Sales (K Dose) by Type (2024-2029)
Table 52. Global Gene Engineered Subunit Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Gene Engineered Subunit Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Gene Engineered Subunit Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Gene Engineered Subunit Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gene Engineered Subunit Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Gene Engineered Subunit Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Gene Engineered Subunit Vaccine Price (US$/Dose) by Type (2018-2023)
Table 59. Global Gene Engineered Subunit Vaccine Price (US$/Dose) by Type (2024-2029)
Table 60. Global Gene Engineered Subunit Vaccine Sales (K Dose) by Application (2018-2023)
Table 61. Global Gene Engineered Subunit Vaccine Sales (K Dose) by Application (2024-2029)
Table 62. Global Gene Engineered Subunit Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Gene Engineered Subunit Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Gene Engineered Subunit Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Gene Engineered Subunit Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gene Engineered Subunit Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Gene Engineered Subunit Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Gene Engineered Subunit Vaccine Price (US$/Dose) by Application (2018-2023)
Table 69. Global Gene Engineered Subunit Vaccine Price (US$/Dose) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 73. Merck Gene Engineered Subunit Vaccine Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 78. GSK Gene Engineered Subunit Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Tiantan Corporation Information
Table 81. Tiantan Description and Business Overview
Table 82. Tiantan Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 83. Tiantan Gene Engineered Subunit Vaccine Product
Table 84. Tiantan Recent Developments/Updates
Table 85. Pulike Corporation Information
Table 86. Pulike Description and Business Overview
Table 87. Pulike Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 88. Pulike Gene Engineered Subunit Vaccine Product
Table 89. Pulike Recent Developments/Updates
Table 90. Greffex Corporation Information
Table 91. Greffex Description and Business Overview
Table 92. Greffex Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 93. Greffex Gene Engineered Subunit Vaccine Product
Table 94. Greffex Recent Developments/Updates
Table 95. CureVac Corporation Information
Table 96. CureVac Description and Business Overview
Table 97. CureVac Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 98. CureVac Gene Engineered Subunit Vaccine Product
Table 99. CureVac Recent Developments/Updates
Table 100. Yebio Corporation Information
Table 101. Yebio Description and Business Overview
Table 102. Yebio Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 103. Yebio Gene Engineered Subunit Vaccine Product
Table 104. Yebio Recent Developments/Updates
Table 105. Sanofi Pasteur SA Corporation Information
Table 106. Sanofi Pasteur SA Description and Business Overview
Table 107. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 108. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product
Table 109. Sanofi Pasteur SA Recent Developments/Updates
Table 110. Virbac Corporation Information
Table 111. Virbac Description and Business Overview
Table 112. Virbac Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 113. Virbac Gene Engineered Subunit Vaccine Product
Table 114. Virbac Recent Developments/Updates
Table 115. Pfizer Inc. Corporation Information
Table 116. Pfizer Inc. Description and Business Overview
Table 117. Pfizer Inc. Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 118. Pfizer Inc. Gene Engineered Subunit Vaccine Product
Table 119. Pfizer Inc. Recent Developments/Updates
Table 120. Walvax Biotechnology Corporation Information
Table 121. Walvax Biotechnology Description and Business Overview
Table 122. Walvax Biotechnology Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 123. Walvax Biotechnology Gene Engineered Subunit Vaccine Product
Table 124. Walvax Biotechnology Recent Developments/Updates
Table 125. Kontec Corporation Information
Table 126. Kontec Description and Business Overview
Table 127. Kontec Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 128. Kontec Gene Engineered Subunit Vaccine Product
Table 129. Kontec Recent Developments/Updates
Table 130. Novavax Corporation Information
Table 131. Novavax Description and Business Overview
Table 132. Novavax Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 133. Novavax Gene Engineered Subunit Vaccine Product
Table 134. Novavax Recent Developments/Updates
Table 135. Sanofi Pasteur Corporation Information
Table 136. Sanofi Pasteur Description and Business Overview
Table 137. Sanofi Pasteur Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 138. Sanofi Pasteur Gene Engineered Subunit Vaccine Product
Table 139. Sanofi Pasteur Recent Developments/Updates
Table 140. Bharat Biotech Corporation Information
Table 141. Bharat Biotech Description and Business Overview
Table 142. Bharat Biotech Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 143. Bharat Biotech Gene Engineered Subunit Vaccine Product
Table 144. Bharat Biotech Recent Developments/Updates
Table 145. GlaxoSmithKline Corporation Information
Table 146. GlaxoSmithKline Description and Business Overview
Table 147. GlaxoSmithKline Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 148. GlaxoSmithKline Gene Engineered Subunit Vaccine Product
Table 149. GlaxoSmithKline Recent Developments/Updates
Table 150. Pfizer Corporation Information
Table 151. Pfizer Description and Business Overview
Table 152. Pfizer Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 153. Pfizer Gene Engineered Subunit Vaccine Product
Table 154. Pfizer Recent Developments/Updates
Table 155. Moderna Corporation Information
Table 156. Moderna Description and Business Overview
Table 157. Moderna Gene Engineered Subunit Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 158. Moderna Gene Engineered Subunit Vaccine Product
Table 159. Moderna Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Gene Engineered Subunit Vaccine Distributors List
Table 163. Gene Engineered Subunit Vaccine Customers List
Table 164. Gene Engineered Subunit Vaccine Market Trends
Table 165. Gene Engineered Subunit Vaccine Market Drivers
Table 166. Gene Engineered Subunit Vaccine Market Challenges
Table 167. Gene Engineered Subunit Vaccine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gene Engineered Subunit Vaccine
Figure 2. Global Gene Engineered Subunit Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Gene Engineered Subunit Vaccine Market Share by Type in 2022 & 2029
Figure 4. Therapeutic Gene Engineered Subunit Vaccine Product Picture
Figure 5. Preventative Gene Engineered Subunit Vaccine Product Picture
Figure 6. Global Gene Engineered Subunit Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Gene Engineered Subunit Vaccine Market Share by Application in 2022 & 2029
Figure 8. Human Use
Figure 9. Veterinary Use
Figure 10. Global Gene Engineered Subunit Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Gene Engineered Subunit Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Gene Engineered Subunit Vaccine Sales (2018-2029) & (K Dose)
Figure 13. Global Gene Engineered Subunit Vaccine Average Price (US$/Dose) & (2018-2029)
Figure 14. Gene Engineered Subunit Vaccine Report Years Considered
Figure 15. Gene Engineered Subunit Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Gene Engineered Subunit Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Gene Engineered Subunit Vaccine Players: Market Share by Revenue in 2022
Figure 18. Gene Engineered Subunit Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Gene Engineered Subunit Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Gene Engineered Subunit Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Gene Engineered Subunit Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. U.S. Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Gene Engineered Subunit Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Gene Engineered Subunit Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Gene Engineered Subunit Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Gene Engineered Subunit Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Gene Engineered Subunit Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Taiwan Gene Engineered Subunit Vaccine

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs